The national drug and device lobbies this week weighed in on a Utah Supreme Court case that could determine whether FDA approval of a medical device shields the product's manufacturer from strict liability claims over alleged design defects. Stuart Gerson, a member of the firm at Epstein Becker Green and a former acting U.S. Attorney General, said the case is drawing national attention because its outcome could have ripple effects in other states. “If you get this in Utah, a...